Aptevo raises $3.0M via registered direct offering of stock and warrants at $0.33/share

Aptevo Therapeutics Inc.

Issued 9,090,910 shares or pre-funded warrants plus warrants for up to 18,181,820 shares at $0.33 per unit.
Gross proceeds ~$3.0M; net proceeds ~$2.5M after fees; proceeds for clinical development and working capital.
Existing warrants covering 11,822,774 shares amended to reduce exercise price from $0.515 to $0.33 per share.
Warrants are exercisable upon stockholder approval and expire five years thereafter; closing occurred September 18, 2024.
Roth Capital Partners acted as exclusive placement agent; 7.0% cash fee on gross proceeds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.